Publicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (20)

2024

  1. Current barriers to initiating insulin therapy in individuals with type 2 diabetes

    Frontiers in Endocrinology, Vol. 15

  2. Ultrasound Cut-Off Values for Rectus Femoris for Detecting Sarcopenia in Patients with Nutritional Risk

    Nutrients, Vol. 16, Núm. 11

2023

  1. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital

    Endocrine Practice, Vol. 29, Núm. 11, pp. 919-927

  2. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  3. Expert Consensus on Morphofunctional Assessment in Disease-Related Malnutrition. Grade Review and Delphi Study

    Nutrients, Vol. 15, Núm. 3

  4. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

    Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1326-1336

  5. Physical activity patterns in type 1 diabetes in Spain: The SED1 study

    BMC Sports Science, Medicine and Rehabilitation, Vol. 15, Núm. 1

2022

  1. Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy

    Diabetes Therapy, Vol. 13, Núm. 7, pp. 1281-1298

  2. Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications

    Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888

2021

  1. Inpatient Hyperglycemia Management and COVID-19

    Diabetes Therapy, Vol. 12, Núm. 1, pp. 121-132

  2. Leading factors for weight gain during covid-19 lockdown in a Spanish population: A cross-sectional study

    Nutrients, Vol. 13, Núm. 3, pp. 1-12

  3. Time-in-range for monitoring glucose control: Is it time for a change?

    Diabetes Research and Clinical Practice, Vol. 177

2020

  1. Consequences of COVID-19 on people with diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 6, pp. 355-356

  2. Factors Accounting for Obesity and Its Perception among the Adult Spanish Population: Data from 1,000 Computer-Assisted Telephone Interviews

    Obesity Facts, Vol. 13, Núm. 4, pp. 322-332

  3. Fish oil enriched intravenous lipid emulsions reduce triglyceride levels in non-critically ill patients with TPN and type 2 diabetes. a post-hoc analysis of the INSUPAR study

    Nutrients, Vol. 12, Núm. 6

  4. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes

    Diabetes Research and Clinical Practice, Vol. 166

  5. Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial

    Clinical Nutrition, Vol. 39, Núm. 2, pp. 388-394

  6. Risk factors for hypoglycemia in inpatients with total parenteral nutrition and type 2 diabetes: A post hoc analysis of the InSUPAR study

    Endocrine Practice, Vol. 26, Núm. 6, pp. 604-611

2016

  1. A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome

    Endocrine Pathology, Vol. 27, Núm. 2, pp. 142-146

2012

  1. Prediction of whole-body and segmental body composition by bioelectrical impedance in morbidly obese subjects

    Obesity Surgery, Vol. 22, Núm. 4, pp. 587-593